Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies
Glycoconjugate Journal · 2024
DOI: 10.1007/s10719-024-10147-w ↗Kurz gefasst
Metaanalyse in der Zeitschrift Glycoconjugate Journal, 2024. Verfasst von Fatemeh Hajizadeh-Sharafabad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. Hauptthemen laut MEDLINE: Glycation End Products, Advanced, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Urmia University of Medical Sciences.
Abstract (Originalsprache)
Advanced glycation end products (AGE) in complex with their receptors (RAGE) cause a chronic inflammatory state in the body, which is the major mechanism in cancer development. This study aimed to conduct a systematic review and meta-analysis on the observational studies investigating the association between AGEs / sRAGE and cancer incidence. The PubMed, Scopus, and Web of Science databases were comprehensively searched to identify papers focused on the associations of sRAGE and AGEs with cancer incidence up to May 2023. Eight studies with a total of 7690 participants were included in the analysis to evaluate the association between circulating sRAGE and cancer incidence. The results indicated that circulating sRAGE (per 100 ng/L) had a significant inverse association with cancer incidence (RR 0.977; 95% CI 0.956, 0.999; p = 0.036; I 2 = 73.3%). The association between AGEs and cancer incidence was evaluated in 8 studies with a total of 3718 individuals. Serum concentrations of AGEs (per 100 µg/L) were not associated with the risk of cancer incidence (RR 0.988; 95% CI 0.974, 1.002; p = 0.08; I2 = 78.8%). Our findings revealed that a higher circulating sRAGE may have a protective effect against cancer incidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
- Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
- Patient Safety Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran. dr.pashaei@yahoo.com.
- Department of Internal Medicine, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran. dr.pashaei@yahoo.com.
Förderung
- Urmia University of Medical Sciences
Zitieren
APA
Hajizadeh-Sharafabad, F., Shojaei-Zarghani, S., Sharifi-Zahabi, E., Gerami, F., & Pashaei, M. R. (2024). Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies. Glycoconjugate Journal. https://doi.org/10.1007/s10719-024-10147-w
Vancouver
Hajizadeh-Sharafabad F, Shojaei-Zarghani S, Sharifi-Zahabi E, Gerami F, Pashaei MR. Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies. Glycoconjugate Journal. 2024. doi:10.1007/s10719-024-10147-w
BibTeX
@article{HajizadehSharafabad2024,
author = {Hajizadeh-Sharafabad, Fatemeh and Shojaei-Zarghani, Sara and Sharifi-Zahabi, Elham and Gerami, Farzad and Pashaei, Mohammad Reza},
title = {Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies},
journal = {Glycoconjugate Journal},
year = {2024},
doi = {10.1007/s10719-024-10147-w}
}
EUVIMED